Tag: JAK

nr-axSpA

First JAK inhibitor approved for nr-axSpA patients

ADC评论 August 1, 2022

On July 29, AbbVie announced that the European Commission (EC) has approved upatinib (15 mg once daily) for the treatment of adults with active non-radiographic

vitiligo

FDA Approves Topical JAK Inhibitor For Vitiligo

ADC评论 July 20, 2022

On July 19, Incyte announced that the FDA approved ruxolitinib cream 1.5% for the topical treatment of non-segmental vitiligo in adults and children over 12

Latest Articles

azide peg linker click chemistry

Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry

October 20, 2023

peg-tco

TCO-Functionalized PEG Derivatives: Versatile Tools for Bioconjugation

October 16, 2023

Tetrazine PEG

Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research

October 8, 2023

endo bcn, exo bcn, bcn peg

BCN Compounds in Pharmaceutical Research and Development

October 6, 2023

cydyes

An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries

September 19, 2023

Protein Conjugation

Unveiling the Power of Protein Conjugation: The Biochemical Game Changer

May 26, 2023

Hot Articles